Implantable light source for optogenic alteration of immune response
Project Overview
The discovery of microbial opsin genes, which is a group of genes that enable the neuron to be activated by light, makes it possible to selectively control activation of neuron by light. Optogenetics is the study that combine genes and the emission of light (optics) together. Our client aims to study how tuberculosis could be treated with neurons stimulated by implantable lights near the lung. Our group’s product is safe to be implanted in mice and can emit light within certain wavelength requirement. The light source can also be switched on and off easily by operator for research use. The light’s intensity is able to trigger all of the neurons inside the lungs of mice.
Team Picture
Files
- Final Poster (December 6, 2018)
- Final Report (December 12, 2018)
- Preliminary Presentation (October 5, 2018)
- PDS (October 9, 2018)
Contact Information
Team Members
- Ruochen Wang - Team Leader
- Marisa Vattendahl Vidal - Communicator
- Jacky Tian - BSAC
- Cassidy Geddes - BWIG
- Jacob Meyertholen - BPAG
Advisor and Client
- Prof. Melissa Skala - Advisor
- Prof. Matyas Sandor - Client
- Martin Hsu - Alternate Contact
Related Projects
- Spring 2020: Implantable light source for optogenic alteration of immune response
- Fall 2019: Implantable light source for optogenic alteration of immune response
- Fall 2018: Implantable light source for optogenic alteration of immune response